Clincosm LogoSign in Get a demo

Prostate Cancer

Showing NaN - NaN of 87
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Glen Burnie, Omaha, Knoxville (PSMA-Targeted [In-111]-Labeled Trillium Compound, PTI-122)

Recruiting
  • Prostate Cancer
  • PSMA-Targeted [In-111]-Labeled Trillium Compound
  • PTI-122
  • Glen Burnie, Maryland
  • +2 more
Mar 21, 2023

Prostate Cancer Trial in Netherlands, United States (Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223)

Recruiting
  • Prostate Cancer
  • Docetaxel 75 mg/m2
  • +2 more
  • Gilbert, Arizona
  • +52 more
Feb 2, 2023

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,

Recruiting
  • Prostate Cancer
  • +5 more
  • 177Lu-rhPSMA-10.1 injection
  • 18F-rhPSMA-7.3 injection
  • Glen Burnie, Maryland
  • +3 more
Feb 2, 2023

Prostate Cancer Trial in United States (ARN-509 (Phase 1), ARN-509 (Phase 2))

Active, not recruiting
Has Results
  • Prostate Cancer
  • ARN-509 (Phase 1)
  • ARN-509 (Phase 2)
  • San Diego, California
  • +14 more
Jan 17, 2023

Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Prostatic Neoplasm
  • abiraterone acetate in combination with prednisone
  • Homewood, Alabama
  • +44 more
Jan 17, 2023

Prostate Cancer Trial in Kogarah, Liverpool, Bedford Park (PCUR-101, Dutasteride 0.5 mg, Abiraterone and Prednisone)

Recruiting
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +4 more
Jan 6, 2023

Prostate Cancer Trial in United States (TAK-700, Bicalutamide)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +559 more
Dec 5, 2022

Prostate Cancer Trial in United States (Apalutamide, LHRH Analogue, Abiraterone Acetate)

Active, not recruiting
  • Prostate Cancer
  • Phoenix, Arizona
  • +68 more
Nov 28, 2022

Prostate Cancer Trial in United States (Apalutamide, Androgen deprivation, Salvage radiation therapy)

Active, not recruiting
  • Prostate Cancer
  • Omaha, Nebraska
  • +4 more
Nov 10, 2022

Prostate Cancer Trial in Worldwide (Abiraterone, Apitolisib, Ipatasertib)

Completed
  • Prostate Cancer
  • Scottsdale, Arizona
  • +58 more
Sep 7, 2022

Prostate Cancer Trial in Worldwide (enzalutamide, abiraterone acetate, prednisone)

Recruiting
  • Prostate Cancer
  • Anchorage, Alaska
  • +126 more
Aug 23, 2022

Prostate Cancer, mCRPC, mCSPC Trial in United States (PRL-02, Prednisone, dexamethasone)

Recruiting
  • Prostate Cancer
  • +2 more
  • Jeffersonville, Indiana
  • +7 more
Aug 17, 2022

Prostate Cancer Trial in Worldwide (Darolutamide, Placebo oral tablet, Luteinizing Hormone-Releasing Hormone Analog)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +74 more
Aug 17, 2022

Prostate Cancer Trial in Worldwide (Apalutamide, Placebo, Androgen Deprivation Therapy (ADT))

Active, not recruiting
Has Results
  • Prostate Cancer
  • Homewood, Alabama
  • +228 more
Aug 2, 2022

Strength, Aging, and Memory in Prostate Cancer

Active, not recruiting
  • Prostate Neoplasm
  • Prostate Cancer
  • Androgen deprivation therapy
  • Omaha, Nebraska
    University of Nebraska Medical Center
Jul 13, 2022

Prostate Cancer Trial in Spain, United States (Capivasertib, Enzalutamide, Abiraterone)

Completed
  • Prostate Cancer
  • Indianapolis, Indiana
  • +5 more
Jul 11, 2022

Prostate Cancer, Bone Metastases, Prostate Tumors Trial in United States (LHRH agonist/antagonist, Bicalutamide, Radium-223

Terminated
Has Results
  • Prostate Cancer
  • +2 more
  • LHRH agonist/antagonist
  • +2 more
  • Phoenix, Arizona
  • +11 more
Jul 7, 2022

Prostate Cancer Trial in Canada, United States (Casodex, Eulexin, LHRH agonist)

Completed
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +260 more
May 23, 2022

Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )

Completed
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +239 more
May 23, 2022

Prostate Cancer Trial in Omaha (64Cu-SAR-bisPSMA)

Not yet recruiting
  • Prostate Cancer
  • 64Cu-SAR-bisPSMA
  • Omaha, Nebraska
    GU Research Network
Mar 9, 2022

Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

Recruiting
  • Pancreatic Cancer
  • +49 more
    • Colorado Springs, Colorado
    • +80 more
    Feb 22, 2022

    Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer, Cancer of the Prostate Trial in Worldwide (Enzalutamide,

    Active, not recruiting
    Has Results
    • Nonmetastatic Castration-Resistant Prostate Cancer
    • +2 more
    • Tucson, Arizona
    • +396 more
    Feb 22, 2022

    Prostate Cancer Trial in Worldwide (Relugolix, Leuprolide Acetate)

    Completed
    Has Results
    • Prostate Cancer
    • Tucson, Arizona
    • +161 more
    Jan 6, 2022

    Prostate Cancer Trial in United States (Zytiga® (Abiraterone Acetate), SoluMatrix™ (Abiraterone Acetate))

    Completed
    Has Results
    • Prostate Cancer
    • Zytiga® (Abiraterone Acetate)
    • SoluMatrix™ (Abiraterone Acetate)
    • Laguna Hills, California
    • +16 more
    Nov 19, 2021

    Prostate Cancer Trial in United States (Abiraterone acetate, Abiraterone acetate plus degarelix, Degarelix)

    Completed
    Has Results
    • Prostate Cancer
    • Abiraterone acetate
    • +2 more
    • Chicago, Illinois
    • +15 more
    Oct 25, 2021